FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387476819> ?p ?o ?g. }

• W4387476819 endingPage "123500" @default.
• W4387476819 startingPage "123500" @default.
• W4387476819 abstract "As the only Food and Drug Administration (FDA)-approved dual-encapsulation liposome injection for treating Acute myeloid leukemia (AML), CPX-351 outperforms the standard chemotherapy treatment “DA 7+3” in terms of clinical effectiveness. Although research on dual-loaded liposomes has increased in recent years, little attention has been paid to their preparation, which can affect their quality, efficacy, and safety. This study explored various preparation processes to create the cytarabine/daunorubicin co-loaded liposome (the Cyt/Daun liposome) and eventually settled on two methods: the sequential loading approach, thin film hydration-extrusion-copper ion gradient, and the simultaneous encapsulation technique, copper ion gradient-concentration gradient. Different preparation methods resulted in different particle sizes and encapsulation efficiencies; the two aforementioned preparation processes generated dual-loaded liposomes with comparable physicochemical properties. The sequential encapsulation technique was selected for the subsequent research owing to its higher encapsulation efficiency prior to purification; the prepared Cyt/Daun liposomes had small and uniform particle size (108.6 ± 1.02 nm, Polydispersity index (PDI) 0.139 ± 0.01), negative charge (-(60.2 ± 1.15) mV), high drug encapsulation efficiency (Cyt 88.2 ± 0.24%, Duan 94.2 ± 0.45%) and good plasma stability. To improve its storage stability, the Cyt/Daun liposome was lyophilized (-40°C for 4 h, maintained for 130 min, and dried for 1200 min) using sucrose-raffinose (mass ratio 7:3; glycolipid ratio 4:1, w/w) as a lyoprotectant. The lyophilized liposomes were purple cakes, redissolved rapidly with insignificant alterations in particle size and encapsulation efficiency, and possessed well storage stability. The pharmacokinetic and tissue distribution studies demonstrated that the Cyt/Daun liposome could achieve long circulation and maintain synergic proportions of drugs within 24 h, increasing the accumulation of drugs at tumor sites. Furthermore, the in vitro/in vivo pharmacodynamic studies confirmed its good anti-tumor activity and safety." @default.
• W4387476819 created "2023-10-11" @default.
• W4387476819 creator A5009374812 @default.
• W4387476819 creator A5013736647 @default.
• W4387476819 creator A5021583927 @default.
• W4387476819 creator A5025212717 @default.
• W4387476819 creator A5025674242 @default.
• W4387476819 creator A5039036151 @default.
• W4387476819 creator A5050080798 @default.
• W4387476819 creator A5063190033 @default.
• W4387476819 creator A5072110622 @default.
• W4387476819 date "2023-10-01" @default.
• W4387476819 modified "2023-10-13" @default.
• W4387476819 title "Research on the preparation process of the cytarabine/daunorubicin dual-encapsulation liposome and its physicochemical properties and performances in vitro/vivo" @default.
• W4387476819 cites W1976973079 @default.
• W4387476819 cites W1981735895 @default.
• W4387476819 cites W1982966474 @default.
• W4387476819 cites W1989304733 @default.
• W4387476819 cites W1992734626 @default.
• W4387476819 cites W1993904936 @default.
• W4387476819 cites W2009570513 @default.
• W4387476819 cites W2015853472 @default.
• W4387476819 cites W2031577180 @default.
• W4387476819 cites W2040448941 @default.
• W4387476819 cites W2060810889 @default.
• W4387476819 cites W2067689242 @default.
• W4387476819 cites W2082440968 @default.
• W4387476819 cites W2083121295 @default.
• W4387476819 cites W2090715900 @default.
• W4387476819 cites W2119367939 @default.
• W4387476819 cites W2137602599 @default.
• W4387476819 cites W2156257249 @default.
• W4387476819 cites W2170507464 @default.
• W4387476819 cites W2494128766 @default.
• W4387476819 cites W2566711870 @default.
• W4387476819 cites W2883399820 @default.
• W4387476819 cites W2908265615 @default.
• W4387476819 cites W2942812484 @default.
• W4387476819 cites W2952090249 @default.
• W4387476819 cites W2965026228 @default.
• W4387476819 cites W2981533670 @default.
• W4387476819 cites W3005979575 @default.
• W4387476819 cites W3006679352 @default.
• W4387476819 cites W3009162149 @default.
• W4387476819 cites W3016599722 @default.
• W4387476819 cites W3089302997 @default.
• W4387476819 cites W3105622149 @default.
• W4387476819 cites W4313823952 @default.
• W4387476819 cites W4319294888 @default.
• W4387476819 doi "https://doi.org/10.1016/j.ijpharm.2023.123500" @default.
• W4387476819 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37820944" @default.
• W4387476819 hasPublicationYear "2023" @default.
• W4387476819 type Work @default.
• W4387476819 citedByCount "0" @default.
• W4387476819 crossrefType "journal-article" @default.
• W4387476819 hasAuthorship W4387476819A5009374812 @default.
• W4387476819 hasAuthorship W4387476819A5013736647 @default.
• W4387476819 hasAuthorship W4387476819A5021583927 @default.
• W4387476819 hasAuthorship W4387476819A5025212717 @default.
• W4387476819 hasAuthorship W4387476819A5025674242 @default.
• W4387476819 hasAuthorship W4387476819A5039036151 @default.
• W4387476819 hasAuthorship W4387476819A5050080798 @default.
• W4387476819 hasAuthorship W4387476819A5063190033 @default.
• W4387476819 hasAuthorship W4387476819A5072110622 @default.
• W4387476819 hasConcept C141071460 @default.
• W4387476819 hasConcept C147789679 @default.
• W4387476819 hasConcept C185154212 @default.
• W4387476819 hasConcept C185592680 @default.
• W4387476819 hasConcept C187530423 @default.
• W4387476819 hasConcept C2776694085 @default.
• W4387476819 hasConcept C2778041864 @default.
• W4387476819 hasConcept C2781021840 @default.
• W4387476819 hasConcept C43617362 @default.
• W4387476819 hasConcept C55493867 @default.
• W4387476819 hasConcept C71924100 @default.
• W4387476819 hasConceptScore W4387476819C141071460 @default.
• W4387476819 hasConceptScore W4387476819C147789679 @default.
• W4387476819 hasConceptScore W4387476819C185154212 @default.
• W4387476819 hasConceptScore W4387476819C185592680 @default.
• W4387476819 hasConceptScore W4387476819C187530423 @default.
• W4387476819 hasConceptScore W4387476819C2776694085 @default.
• W4387476819 hasConceptScore W4387476819C2778041864 @default.
• W4387476819 hasConceptScore W4387476819C2781021840 @default.
• W4387476819 hasConceptScore W4387476819C43617362 @default.
• W4387476819 hasConceptScore W4387476819C55493867 @default.
• W4387476819 hasConceptScore W4387476819C71924100 @default.
• W4387476819 hasLocation W43874768191 @default.
• W4387476819 hasLocation W43874768192 @default.
• W4387476819 hasOpenAccess W4387476819 @default.
• W4387476819 hasPrimaryLocation W43874768191 @default.
• W4387476819 hasRelatedWork W1818146702 @default.
• W4387476819 hasRelatedWork W1964648983 @default.
• W4387476819 hasRelatedWork W2071961017 @default.
• W4387476819 hasRelatedWork W2147459960 @default.
• W4387476819 hasRelatedWork W2367606374 @default.
• W4387476819 hasRelatedWork W2801436543 @default.
• W4387476819 hasRelatedWork W2902719404 @default.
• W4387476819 hasRelatedWork W3046856303 @default.

• next